Implementation of robotic hernia surgery using the Versius® system

Dixon, Frances; Qureshi, Adnan; Vitish-Sharma, Parveen; Khanna, Arun; Keeler, Barrie

doi:10.1007/s11701-022-01451-4

Cited by 9 publications

(3 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A systematic review by Alkatout et al analyzed the timeline of preclinical and clinical studies, which con rmed the feasibility and safety of the Versius platform [9]. Thereafter, the Versius has been used for cholecystectomy, general abdominal surgery, hernia repair, radical prostatectomy, and renal surgery [10][11][12][13][14][15]. We recently reported a detailed description of the Versius surgical management of pelvic organ prolapse, by using the Shull surgical technique [16].…”

Section: Discussionmentioning

confidence: 99%

Robotic excision of parametrial endometriosis with the new Versius robotic system: a preliminary case series.

Gaia,

Afonina,

Felline

et al. 2023

Preprint

View full text Add to dashboard Cite

Purpose: Endometriosis affects 10% of the female population in reproductive age. Although a greater awareness of the condition and constant progress in understanding its natural history, its treatment remain challenging. When it comes to surgical intervention, the minimally invasive, laparoscopic, or robotic approach is the gold standard. While offering better visualization and refinement of movements, the robotic system is burdened by often unaffordable costs. Since the Da Vinci patent expired, new platforms have entered this scene, trying to preserve the advantages of robotics, while cutting costs. To date, there are no deep infiltrating endometriosis cases reported in literature afforded with the new Versius surgical system. Materials and methods: We considered prospectively 3 patients undergoing robotic surgery for parametrial endometriosis with the versius system, in our tertiary referral multiplatform robotic center. The surgical technique was described step by step. Demographics, intra-operative robotic events and peri-operative outcomes were collected. Results: A total of 3 procedures were performed. The median BMI was 18.52 kg/m 2, [16.33-20.96]. The median age was 41 years [36-51]. Median docking time was 51 minutes [37-60], median console time 180 [136-223] minutes. Pneumoperitoneum was maintained at 9 mmHg. A single high priority collision occurred. Blood loss was negligible. There were no peri-operative complications nor conversions. Conclusions: Versius appeared to be a safe and feasible option for deep infiltrating endometriosis surgery. Our experience suggests operative room configuration and port placement to better perform these challenging procedures. These suggestions may enhance the mini-invasiveness while beating costs and making robotics worldwide approachable.

show abstract

Section: Discussionmentioning

confidence: 99%

Robotic excision of parametrial endometriosis with the new Versius robotic system: a preliminary case series.

Gaia,

Afonina,

Felline

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

“…The usability of both systems has been recently evaluated in both the preclinical 6,7 and the clinical setting. 8 –11…”

Section: Introductionmentioning

confidence: 99%

“…The usability of both systems has been recently evaluated in both the preclinical 6,7 and the clinical setting. [8][9][10][11] The hinotori™ robotic system is a novel surgical robot developed by Medicaroid (Medicaroid Corporation, Kobe, Japan). The hinotori™ consists of a full high-vision 3D console and a patient-side cart with four eight-axis robotic arms (Figure 1), 12 designed to reduce the arm-to-arm or the arm-to-assistant interference for smoother movements.…”

Section: Introductionmentioning

confidence: 99%

Medicaroid robotic assisted surgery system: A feasibility study

Capovilla

Froiio

Hadzijusufoviç

et al. 2023

International Journal of Advanced Robotic Systems

View full text Add to dashboard Cite

The hinotori™ surgical robotic system, by Medicaroid (Medicaroid Corporation, Kobe, Japan), is a new robotic system for minimally invasive surgery. We aimed at evaluating its usability and accessibility in a preclinical setting. This was a preclinical feasibility study. Two groups of surgeons, one with three experienced robotic surgeons (group 1) and one with three robotic-surgery naive participants (group 2), performed the following tasks using the hinotori™ system in a simulated preclinical setting: console setup, docking, instrument exchange, undocking, and suturing. Each participant repeated each task three times. The time required for performing each repetition and the count of failed repetitions were the primary outcomes of the study. The subjectively perceived workload in performing the tasks, as measured by the NASA-TLX score, was the secondary outcome. The improvement of participants within the three repetitions as well as a comparison between the performances of group 1 and 2 were evaluated. The time required to perform each task decreased with repetitions for both groups, so did the subjective workload score. The time measures required to perform the tasks and the mental effort scores were comparable between the two groups for the console setup, docking, instrument exchange, and undocking tasks. The NASA-TLX score was also comparable between the two groups for the console setup and the emergency undocking tasks and decreased significantly within all tasks after the third repetition. The incidence of failed repetitions was higher in group 2 for the suturing task, however the difference was not statistically significant. The results confirmed the usability of the hinotori™ system in a preclinical setting for both highly trained surgeons and nonexperienced operators and its accessibility for both long-time users of other systems and first-time users.

show abstract